Activity

UTAK Validity 2 Discussion - Touchpoint - October 15 VIEW RECORDING: https://fathom.video/share/xkcUrqaTN2g4xWY5uhtZHES-stoLRFai Order status update @ 3:12 Nicole provided an update on the UTAK orders for Siemens, noting that the orders with 6-month expiration have shipped and should have been received. The testing of the new 24-month expiration design is still ongoing, with the last set of samples expected to be sent to Siemens next week or the week after. UTAK is waiting to receive the results from Siemens on the first two sets of 24-month expiration samples. Upcoming 24-month expiration data @ 4:00 Nicole explained that once UTAK receives the results from Siemens on the final set of 24-month expiration samples, they will be able to compare the data to their expectations and determine the new expiration date. The team hopes to have all the data back from Siemens by the next meeting, so they can discuss the timeframes and the results. UTAK Validity 2 Discussion - Touchpoint - October 15 VIEW RECORDING - 6 mins (No highlights): https://fathom.video/share/xkcUrqaTN2g4xWY5uhtZHES-stoLRFai --- 0:02 - Nicole Miller Yeah, we did. 0:06 - Raleigh Gallina (UTAK Laboratories) Hey, Jingkun, how are you? Hello. We'll tight and wait for others to join since we're just getting started. All right, we have Rory and Robin joining us. Hello, hello. Can you hear us, Rory and Robin? I can. 0:41 - Madigan, Rorie (Siemens Healthineers) How are you? Hey, yes. 0:44 - Raleigh Gallina (UTAK Laboratories) How are you both doing? Good. 0:46 - Madigan, Rorie (Siemens Healthineers) How are you? Good, good. 0:48 - Raleigh Gallina (UTAK Laboratories) Doing well. No complaints. for the time. 0:52 - Madigan, Rorie (Siemens Healthineers) No, no, it's all good. 0:54 - Raleigh Gallina (UTAK Laboratories) I mean, as you can see, it worked for a number of us, so we all might have needed an adjustment. We'll hang tight while we have others joining the call here. Hey, Aline, thanks for hopping on. Hey, everyone. All right, we'll give it a few more minutes, and then we'll jump right in. You Thank All right. I'll so go ahead and get started. I know Rima was out of office, and I know that Jim is always wall-to-wall with meetings as well, but feel free to reach out if any of you need the recording from today, and you can go ahead and pass it along. So welcome to our regularly scheduled Validity II discussion. On our end on the UTAK side, we're going to go ahead and be providing updates as we have them here. And of course, if anything comes up interim as urgent, we would reach out as well. And then we can go ahead and take any questions from the Siemens team as well. Nicole, would you be able to share updates on our end? Sure. 3:12 - Nicole Miller So for, I looked at there was two orders for Siemens that were due for October. So those ones have shipped out. think they should be received probably at this point. So that's with the six-month expiration, same design as we have currently. So that closed those. Then the updates for the testing of the new design for the 24-month expiration is still ongoing. So we've got about two-thirds of it completed. I think the last set of samples are due to be sent to Siemens, I think, next week or early the week after. I don't think we've seen any results from the first two sets of samples that we've shipped for this trial batch. So we were unsure if there's some sort of delay that's happened. But really, we just need the data after that last set of samples ships. So once we have those results all in, then we're able to proceed with the next steps of comparing the results to what we expect and then establishing what that new expiration date is, depending on what the results come back as. So by the next meeting, I would hope that we can have all the data back from Siemens for those samples so we can have a bit more of an idea of timeframes and how that data is looking compared to what we expect it to look like. Are there any questions I can answer? 4:35 - Li, Jingkun (Siemens Healthineers) We do have one sample being tested this week. You should have the result at the end of this week. Okay, perfect. 4:47 - Nicole Miller All right. Well, if there's nothing else, I think that's it from the UTAK side, right, Rorie? Confirm. Yes, no, that's correct. 4:57 - Raleigh Gallina (UTAK Laboratories) Okay, these are, our updates tend to be. We're brief and give people time back. Was there anything else on the Siemens side? Nothing from me. 5:07 - Madigan, Rorie (Siemens Healthineers) Thank you for the update. 5:11 - Raleigh Gallina (UTAK Laboratories) Great. Well, wishing everyone a beautiful finish to your week, and we'll be in touch if we have updates before our next call. Thanks so much. Have a great rest of your day. 5:20 - Madigan, Rorie (Siemens Healthineers) You too. Thank you. Bye. 5:23 - Andrew Hartmann Bye. Bye. Siemens sample testing update @ 4:35 Jingkun from Siemens confirmed that they have one sample being tested this week, and UTAK should receive the results by the end of the week. Meeting wrap-up @ 4:57 Raleigh noted that the UTAK updates are typically brief to give people time back. He asked if there was anything else from the Siemens side, to which Rorie replied there was nothing further. Raleigh wished everyone a good rest of the week and said UTAK will be in touch if they have any updates before the next call.